Pusiliva
普世利华
Pusiliva
Biotech/Healthcare
Pushilihua is committed to using next-generation genetic technologies to develop innovative molecular-diagnostics products and explore applications of gene therapy that can improve health and quality of life.
Latest round: Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.